Structure of recombinant human rheumatoid arthritic synovial fluid phospholipase A2 at 2.2 Å resolution JP Wery, RW Schevitz, DK Clawson, JL Bobbitt, ER Dow, G Gamboa, ... Nature 352 (6330), 79-82, 1991 | 269 | 1991 |
Gene clustering using self-organizing maps and particle swarm optimization X Xiao, ER Dow, R Eberhart, ZB Miled, RJ Oppelt Proceedings international parallel and distributed processing symposium, 10 pp., 2003 | 241 | 2003 |
Temporal gene expression analysis of monolayer cultured rat hepatocytes TK Baker, MA Carfagna, H Gao, ER Dow, Q Li, GH Searfoss, TP Ryan Chemical research in toxicology 14 (9), 1218-1231, 2001 | 204 | 2001 |
Discovery of sequence motifs related to coexpression of genes using evolutionary computation GB Fogel, DG Weekes, G Varga, ER Dow, HB Harlow, JE Onyia, C Su Nucleic Acids Research 32 (13), 3826-3835, 2004 | 131 | 2004 |
Integrative analysis reveals a molecular stratification of systemic autoimmune diseases G Barturen, S Babaei, F Català‐Moll, M Martínez‐Bueno, Z Makowska, ... Arthritis & rheumatology 73 (6), 1073-1085, 2021 | 125 | 2021 |
The use of neural networks for variable selection in QSAR JH Wikel, ER Dow Bioorganic & Medicinal Chemistry Letters 3 (4), 645-651, 1993 | 123 | 1993 |
Molecular profile of catabolic versus anabolic treatment regimens of parathyroid hormone (PTH) in rat bone: an analysis by DNA microarray JE Onyia, LM Helvering, L Gelbert, T Wei, S Huang, P Chen, ER Dow, ... Journal of cellular biochemistry 95 (2), 403-418, 2005 | 122 | 2005 |
Assessment of diet‐induced obese rats as an obesity model by comparative functional genomics S Li, HY Zhang, CC Hu, F Lawrence, KE Gallagher, A Surapaneni, ... Obesity 16 (4), 811-818, 2008 | 87 | 2008 |
Changes in osteoblast, chondrocyte, and adipocyte lineages mediate the bone anabolic actions of PTH and small molecule GSK‐3 inhibitor NH Kulkarni, T Wei, A Kumar, ER Dow, TR Stewart, J Shou, M N'cho, ... Journal of cellular biochemistry 102 (6), 1504-1518, 2007 | 79 | 2007 |
Gene expression and pharmacodynamic changes in 1,760 systemic lupus erythematosus patients from two phase III trials of BAFF blockade with tabalumab RW Hoffman, JT Merrill, MME Alarcón‐Riquelme, M Petri, ER Dow, ... Arthritis & rheumatology 69 (3), 643-654, 2017 | 75 | 2017 |
IL-17 induces inflammation-associated gene products in blood monocytes, and treatment with ixekizumab reduces their expression in psoriasis patient blood CQF Wang, M Suarez-Farinas, KE Nograles, CA Mimoso, D Shrom, ... The Journal of investigative dermatology 134 (12), 2990, 2014 | 65 | 2014 |
A statistical analysis of the TRANSFAC database GB Fogel, DG Weekes, G Varga, ER Dow, AM Craven, HB Harlow, EW Su, ... Biosystems 81 (2), 137-154, 2005 | 56 | 2005 |
Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple … T Dörner, Y Tanaka, MA Petri, JS Smolen, DJ Wallace, ER Dow, RE Higgs, ... Lupus Science & Medicine 7 (1), e000424, 2020 | 52 | 2020 |
Differential effects of estrogen and raloxifene on messenger RNA and matrix metalloproteinase 2 activity in the rat uterus LM Helvering, MD Adrian, AG Geiser, ST Estrem, T Wei, S Huang, P Chen, ... Biology of reproduction 72 (4), 830-841, 2005 | 48 | 2005 |
A hybrid self‐organizing maps and particle swarm optimization approach X Xiao, ER Dow, R Eberhart, Z Ben Miled, RJ Oppelt Concurrency and Computation: Practice and Experience 16 (9), 895-915, 2004 | 43 | 2004 |
Evolutionary computation for discovery of composite transcription factor binding sites GB Fogel, VW Porto, G Varga, ER Dow, AM Craven, DM Powers, ... Nucleic acids research 36 (21), e142-e142, 2008 | 36 | 2008 |
Automated analysis of proton NMR spectra from combinatorial rapid parallel synthesis using self-organizing maps S Kalelkar, ER Dow, J Grimes, M Clapham, H Hu Journal of combinatorial chemistry 4 (6), 622-629, 2002 | 33 | 2002 |
Expression profiling of rat femur revealed suppression of bone formation genes by treatment with alendronate and estrogen but not raloxifene LM Helvering, R Liu, NH Kulkarni, T Wei, P Chen, S Huang, F Lawrence, ... Molecular pharmacology 68 (5), 1225-1238, 2005 | 30 | 2005 |
Mechanism of action of baricitinib and identification of biomarkers and key immune pathways in patients with active systemic lupus erythematosus T Dörner, Y Tanaka, ER Dow, AE Koch, M Silk, JAR Terres, JT Sims, ... Annals of the rheumatic diseases 81 (9), 1267-1272, 2022 | 29 | 2022 |
Self-organizing maps for the analysis of NMR spectra LK Dow, S Kalelkar, ER Dow Drug Discovery Today: BIOSILICO 2 (4), 157-163, 2004 | 25 | 2004 |